BHOPAL: The MP SIT probing the Coldrif tragedy that claimed the lives of 20 kids from Chhindwara and three from other districts is examining the entire supply chain of the cough syrup — from procurement of raw materials to distribution of the contaminated drug — aiming to fix accountability at every stage. Investigators confirmed that Ranganathan Govindan, owner of TN-based Sresan Pharmaceuticals, had procured banned industrial-grade diethylene glycol for manufacturing Coldrif. The SIT is now trying to determine how long the chemical had been in use and whether other individuals or suppliers were complicit in the process.Ranganathan initially feigned ignorance about the cause of contamination, claiming he had delegated production responsibilities to subordinates. DEG test now must

See Full Page